As per FDA approval in 2021, it's indicated for chronic weight management in adults with obesity or overweight with at least one weight-related condition such as high blood pressure, type 2 diabetes mellitus or high cholesterol (hyperlipidemia)
GIP activation enhances leptin sensitivity, increases energy expenditure, and improves how efficiently cells use glucose and fat
This is a significant distinction from over-the-counter GLP-1 supplements, which may not provide the same level of efficacy or safety
Option 3: Consider semaglutide If tirzepatide isnt covered but weight loss treatment is a priority, semaglutide products (Wegovy or Ozempic) may have better coverage on your specific plan
A medication can be promising without being a dementia-prevention protocol
Others use it as a temporary catalyst, eventually tapering off